跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Gilead Sciences Ireland Unlimited Company
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 26, 2021
Approval ID
14e50e16043badca
Company
Gilead Sciences Ireland Unlimited Company
Type
Standard
Approval Details
Approval Id
14e50e16043badca
Drug Cima Aemps Name
TRODELVY 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1211592001
Holder Company Name
Gilead Sciences Ireland Unlimited Company
Marketing Company Name
Gilead Sciences S.L.
Holder Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Authorization Date
2021-11-26
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
200 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Gilead Sciences Ireland Unlimited Company
Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Company Information
Pharmaceutical Company Name
GILEAD SCIENCES IRELAND UNLIMITED COMPANY
Country Name
Ireland
City Name
carrigtwohill,country_ie
Address
Ida Business & Technology Park
Active Ingredients
SACITUZUMAB GOVITECAN
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 26, 2021
Approval ID
14e50e16043badca
Type
Standard
Back to CIMA-AEMPS Approvals